【レポートの概要(一部)】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hemophilia Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users, by region / by product / by country
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.2. Rising neonatal population driving diagnostic rate
3.7.3. Favorable government initiatives
3.7.4. Rising R & D and new product development
3.7.5. Rising adoption for prophylaxis treatment
3.7.6. Market Restraint Analysis
3.7.7. High cost of treatment
3.7.8. Industry Challenges
3.7.9. Low adoption rate to advanced technologies
3.8. Hemophilia: Market Analysis Tools
3.8.1. Industry Analysis – Porter’s
3.8.1.1. Supplier Power: (Low)
3.8.1.2. Buyer Power: (Moderate)
3.8.1.3. Substitution Threat: (Moderate)
3.8.1.4. Threat from new entrant: (Moderate)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
Chapter 4. Hemophilia Market: Segment Analysis, By Type, 2015 – 2026 (USD Million)
4.1. Definitions & Scope
4.2. Type market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Hemophilia Market, by Type, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Hemophilia A
4.5.2. Hemophilia B
4.5.3. Hemophilia C
4.5.4. Others
Chapter 5. Hemophilia Market: Segment Analysis, By Treatment, 2015 – 2026 (USD Million)
5.1. Definitions & Scope
5.2. Type market share analysis, 2018 & 2026
5.3. Segment Dashboard
5.4. Global Hemophilia Market, by Treatment, 2015 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
5.5.1. Replacement therapy
5.5.2. ITI therapy
5.5.3. Gene therapy
Chapter 6. Hemophilia Market: Segment Analysis, By Therapy, 2015 – 2026 (USD Million)
6.1. Definitions & Scope
6.2. Type market share analysis, 2018 & 2026
6.3. Segment Dashboard
6.4. Global Hemophilia Market, by Therapy, 2015 to 2026
6.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
6.5.1. On-demand
6.5.2. Prophylaxis
Chapter 7. Hemophilia Market: Regional Market Analysis, 2015 – 2026 (USD Million)
7.1. Definitions & Scope
7.2. Regional market share analysis, 2018 & 2026
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.5. Regional Market Share and Leading Players, 2018
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
7.6.1. North America
7.6.2. Europe
7.6.3. Asia Pacific
7.6.4. Latin America
7.6.5. Middle East & Africa
7.7. Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
7.8. North America
7.8.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.8.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.8.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.8.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.8.5. U.S.
7.8.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.8.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.8.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.8.6. Canada
7.8.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.8.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.8.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9. Europe
7.9.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.9.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.5. Germany
7.9.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.6. UK
7.9.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.7. France
7.9.7.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.7.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.7.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.8. Italy
7.9.8.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.8.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.8.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.9. Spain
7.9.9.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.9.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.9.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10. Asia Pacific
7.10.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.10.1.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.1.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.1.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.2. China
7.10.2.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.2.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.2.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.3. Japan
7.10.3.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.3.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.3.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.4. India
7.10.4.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.4.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.4.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.5. Thailand
7.10.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.6. South Korea
7.10.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11. Latin America
7.11.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.11.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.5. Brazil
7.11.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.6. Mexico
7.11.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.7. Argentina
7.11.7.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.7.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.7.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.8. Columbia
7.11.8.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.8.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.8.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12. Middle East and Africa
7.12.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.12.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12.5. South Africa
7.12.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12.6. Saudi Arabia
7.12.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12.7. UAE
7.12.7.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.7.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.7.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
Chapter 8. Hemophilia Market – Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2018
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company Market Share/Ranking, by region
8.4.3. Competitive Dashboard Analysis
8.4.3.1. Market Differentiators
8.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
8.5. Private Companies
8.5.1. List of key emerging companies’ /technology disruptors/innovators
8.5.2. Funding Outlook (Optional)
8.5.3. Regional network map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.6. Supplier Ranking
8.7. Key companies profiled
8.7.1. Novo Nordisk
8.7.1.1. Company Overview
8.7.1.2. Financial Performance
8.7.1.3. Product Benchmarking
8.7.1.4. Strategic Initiatives
8.7.2. Biogen.
8.7.2.1. Company Overview
8.7.2.2. Financial Performance
8.7.2.3. Product Benchmarking
8.7.2.4. Strategic Initiatives
8.7.3. Chugai Pharmaceutical
8.7.3.1. Company Overview
8.7.3.2. Financial Performance
8.7.3.3. Product Benchmarking
8.7.3.4. Strategic Initiatives
8.7.4. Bayer Healthcare
8.7.4.1. Company Overview
8.7.4.2. Financial Performance
8.7.4.3. Product Benchmarking
8.7.4.4. Strategic Initiatives
8.7.5. Pfizer.
8.7.5.1. Company Overview
8.7.5.2. Financial Performance
8.7.5.3. Product Benchmarking
8.7.5.4. Strategic Initiatives
8.7.6. Shire Plc
8.7.6.1. Company Overview
8.7.6.2. Financial Performance
8.7.6.3. Product Benchmarking
8.7.6.4. Strategic Initiatives
8.7.7. Baxalta (Baxter Healthcare)
8.7.7.1. Company Overview
8.7.7.2. Financial Performance
8.7.7.3. Product Benchmarking
8.7.7.4. Strategic Initiatives
8.7.8. CSL Behring.
8.7.8.1. Company Overview
8.7.8.2. Financial Performance
8.7.8.3. Product Benchmarking
8.7.8.4. Strategic Initiatives
8.7.9. Octapharma.
8.7.9.1. Company Overview
8.7.9.2. Financial Performance
8.7.9.3. Product Benchmarking
8.7.9.4. Strategic Initiatives
Chapter 9. KOL Commentary
Chapter 10. Recommendations
【レポート販売概要】
■ タイトル:血友病の世界市場:タイプ別(血友病A、血友病B、血友病C)、治療別(オンデマンド療法、予防投与)、治療別(補充療法、遺伝子治療)、セグメント予測■ 英文:Hemophilia Market Analysis by Type (Hemophilia A, Hemophilia B, Hemophilia C), by Treatment (On-demand, Prophylaxis), by Therapy (Replacement Therapy, Gene Therapy), And Segment Forecasts, 2019 - 2026
■ 発行日:2019年2月25日
■ 調査会社:Grand View Research
■ 商品コード:GVW903090
■ 調査対象地域:グローバル
- 歯科矯正装置の世界市場:ブラケット(自己結紮式、リンガル)、アーチワイヤー、固定デバイス(頬面管、バンド、アンカースクリュー)The global orthodontic supplies market is poised to reach USD 3,978.6 million by 2020, growing at a CAGR of 6.9% during the forecast period. Although mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the orthodontic supplies market, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as growing number of p …
- 3M ESPE Dental Products:市場シェア分析3M ESPE Dental Products Market Share Analysis Summary GlobalData’s new report, “3M ESPE Dental Products Market Share Analysis” provides in-depth information on 3M ESPE Dental Products’s market position in the different medical equipment markets it operates in. The report provides 3M ESPE Dental Products market share information in four key market categories – Crowns and Bridges, CAD/CAM Dental Sys …
- インテリジェント自動販売機の世界市場の規模と分析:タイプ別(ホットドリンク、スナック、パッケージドリンク)、用途別(QSR、ショッピングモール、小売店、オフィス、公共交通機関)、地域別、セグメント予測、2014-2025The global intelligent vending machines market is expected to reach USD 11.84 billion by 2025, according to a new study by Grand View Research, Inc. The surge in the penetration of self-services technology across North America and Europe is anticipated to drive the industry growth over the next nine years. Intelligent vending machines incorporate energy efficient electronic equipment including eff …
- オートバイレンタルの世界市場2016-2020About Motorcycle RentalThe motorcycle rental market is a flourishing trade providing value to commuters and to tourists and travelers who look to rent motorcycles for recreational purposes. The rental market allows users to rent motorcycles of their preference, which may be renting a high brand motorcycle such as Harley-Davidson, Kawasaki, and Royal Enfield. Technavio’s analysts forecast the globa …
- 熱障壁コーティング(TBC)の世界市場分析:製品別(金属、セラミック、金属間化合物)、技術別(EB-PVD、HVOF、CVD、エアプラズマ)、コーティングコンビネーション別(セラミックYSZ、Al 2 O 3、MCrAlY、ムライトベース)、用途別(固定発電所、航空宇宙、自動車)、セグメント予測The global thermal barrier coatings market is expected to reach a market size of USD 22.30 billion by 2024, according to a new report by Grand View Research, Inc. The industry is expected to witness significant growth over the forecast period owing to the increased adoption of air plasma and vapor deposition technologies for coating application, thereby increasing the demand from various applicati …
- 飼料プレミックスの世界市場2018-2022112 pages, October 2018 About this market The increase in capacity expansions and new plants will boost the market growth. The rise in demand for food premixes has been attracting producers to expand their food capacities. Hence, the market has gone many expansions. Technavio’s analysts have predicted that the feed premix market will register a CAGR of more than 3% by 2022. Market Overview Increas …
- マイクロチャンネル熱交換器の世界市場展望2017-2026According to Stratistics MRC, the Global Microchannel Heat Exchanger Market is accounted for $8.74 billion in 2017 and is expected to reach $29.57 billion by 2026 growing at a CAGR of 14.5% during the forecast period. Some of the key factors influencing the market growth include increasing demand for HVACR industry and energy efficiency regulations. However, the production of low-cost in emerging …
- サリチル酸の世界市場2015-2019Technavio’s market research analyst predicts the global salicylic acid market to grow at a CAGR of around 9% during the forecast period. The increased use of salicylic acid in the manufacture of aspirin and its extensive application in the pharmaceutical sector is the primary driver for the growth of the market. The increased preference for preserved food and beverages among consumers is anticipat …
- 航空機用燃料装置の世界市場2016-2020About Aircraft Fuel Systems A fuel system consists of storage tanks, valves, pumps, filters, metering devices, fuel lines, and monitoring devices. It allows the fuel to pass to the auxiliary power unit (APU) and propulsion system. These devices are designed, developed, and certified under the Code of Federal Regulations (14 CFR) guidelines. Fuel systems largely depend on the size and complexity of …
- FPGAの世界市場:SRAM型FPGA、アンチヒューズFPGA、フラッシュFPGAInternet availability is required for many mobile devices including smartphones, laptops, or tablets. We have seen a huge growth in the market of these devices and in coming years, the market of these devices is expected to experience a huge growth. Owing to the huge market size for smartphones, tablets, and laptops, the number of internet users has also increased across the world; however, the pr …
- 車輪トラクタの世界市場2015-2019About wheeled tractor Wheeled tractors are used on the construction site for lifting and loading materials such as asphalt, dirt, snow, logs, raw materials, debris, rocks, and sand. These tractors can be easily converted to loaders with attachments such as dozer blades, buckets, and rippers. One of the major drivers propelling market growth is the increased investment in infrastructure projects. R …
- 食品用酵素の世界市場:カルボヒドラーゼ、プロテアーゼ、リパーゼAbout Enzymes Enzymes are complex proteins that help accelerate reactions and catalyze biochemical reactions. They increase the reaction rates by lowering the activation energy of the reactants. Small quantities of enzymes are enough to increase the reaction rates up to a million times on account of their specific mode of action. Most of the enzymes are found to function in a narrow set of conditi …
- Drax Group plc:発電所及びSWOT分析2013Drax Group plc - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and deta …
- 甲状腺濾胞がん(Follicular Thyroid Cancer)の治療薬パイプライン動向(2015年上半期版)Follicular Thyroid Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Follicular Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Follicular Thyroid Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Follicular Thyroid Cancer, complete with comparative analysis at various stages, therapeutics asse …
- スマート教室向け書画カメラの世界市場2015-2019About document cameras Document cameras, also known as visualizers or digital visual presenters, refer to devices used to project images of three-dimensional objects placed under the camera. It makes teaching/lectures more interactive and comprehensive. Although it can be used in any type of classroom, it is mostly used in technical institutions that involve the study of complex concepts. However, …